The firm advised the Corporación Andina de Fomento (CAF) on the equity investment of Patia Biopharma, for the development of a cost-efficient genetic test to identify high-risk patients of diabetes that may get SARS-Cov-2 in order to adopt precautionary measures, through the run of tests and samples compilations in Spain, Mexico and Peru.
“Nader Hayaux Goebel lead sale of a minority stake in Grupo de Diagnostico Aries to Caisse de dépôt et placement du Québec (CDPQ”
Grupo de Diagnostico Aries entered into a definitive agreement to sell a 20.25% stake to Caisse de dépôt et placement du Québec, as a result of a process organized and structured by BBVA with the advice of Nader Hayaux Goebel.
It was considered as one of the most attractive private equity deals of 2021, that attracted the interest of many private equity funds. This a new transaction by the firm in the health industry where it is a market leader.
The firm acted as Mexican legal counsel to Upper90 Capital Management, LP on a Senior Secured Term Loan for USD $50 million, secured by a first priority lien on all assets and shares of Valoreo, Inc and subsidiaries, including equity interest in and assets of Valoreo Mexican subsidiaries.